BRCA Testing in Serbia and Montenegro

Hereditary Cancer in Clinical Practice

Mirjana Brankovic-Magic¹ 

[1] Institute for Oncology and Radiology of Serbia, Pasterova 14, 11 000 Belgrade, Serbia and Montenegro

关键词: HBOC;    BRCA1 and BRCA2 testing;   

Others  :  811919
DOI  :  10.1186/1897-4287-4-1-12

 received in 2005-07-30, accepted in 2005-10-15,  发布年份 2006

   

【 参考文献 】

• [1]Ferlay J, Bray F, Pisani P, Parkin DM, GLOBOCAN 2000: Cancer incidence, mortality and prevalence worldwide. IARC CancerBase, No 5, Lyon, IARC Press; 2001.
• [2]Papp J, Raicevic L, Milašin J, Dimitrijević B, Radulović S, Olah E: Germline mutation analysis of BRCA1 and BRCA2 genes in Yugoslav breast/ovarian cancer families. Oncol Rep 1999, 6:1435-1438.
• [3]Konstantopoulou I, Janković R, Raièević L, Ladopoulou A, Armaou S, Nikopoulos G, Pandis N, Nasioulas G, Radulović S, Yannoukakos D: BRCA1 and BRCA2 genes mutation analysis in patients with a family history of breast and ovarian cancer. Jugoslav Med Biochem 2004, 23:271-277.
• [4]Hampel H, Sweet K, Westman JA, Offit K, Eng C: Referral for cancer genetics consultation: a review and compilation of risk assessment criteria. J Med Genet 2004, 41:81-91.
• [5]Gorski B, Byrski T, Huzarski T, Jakubowska A, Menkiszak J, Gronwald J, Pluzanska A, Bebenek M, Fischer-Maliszewska L, Grzybowska E, Narod SA, Lubinski J: Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer. Am J Hum Genet 2000, 66:1963-1968.